Fund BasicsSee More
- Fund Family SmartETFs
- Assets Under Management 2,893,000
- Shares Outstanding, K 100
- 60-Month Beta 1.90
- Price/Earnings ttm 39.87
- Annual Dividend & Yield N/A (0.00%)
- Most Recent Dividend N/A on N/A
- Management Fee 0.68%
|Period||Period Low||Period High||Performance|
| || |
+0.42 (+1.48%)since 08/27/21
| || |
+0.06 (+0.21%)since 06/25/21
The technology sector has been on a selling spree lately thanks to renewed inflation fears. Investors should buy the dip in the sector.
Guinness Atkinson Asset Management today announced the launch of the SmartETFs Advertising & Marketing Technology ETF (NYSE: MRAD), an actively managed global investment strategy with fully transparent...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today that Medicare has expanded coverage for BRACAnalysis CDx for men with prostate cancer who...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today that a new study published in Future Medicine demonstrates the ability of myPath Melanoma...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, announced today that the company has received favorable coverage decisions for Prolaris from three new commercial...
Naspers Limited's ("Naspers" or the "Company") (JSE: NPN; LSE: NPSN): further to the announcement released today by Myriad International Holdings N.V. (to be renamed Prosus N.V. with effect from the Settlement...
|3rd Resistance Point||29.00|
|2nd Resistance Point||29.00|
|1st Resistance Point||29.00|
|1st Support Level||29.00|
|2nd Support Level||29.00|
|3rd Support Level||29.00|